Looking back: how does a new diabetes drug perform in the real world?
NCT ID NCT07457580
Summary
This study aims to understand how the drug teplizumab is used in real-world medical practice for people with early-stage type 1 diabetes. Researchers will review the medical records of about 60 people who have already received this treatment. The goal is to learn about the patients' characteristics and how their diabetes progressed after treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 1 DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Investigational Site Number: 3800003
RECRUITINGPalermo, 90127, Italy
-
Investigational Site Number: 7240002
RECRUITINGMadrid, 28046, Spain
Conditions
Explore the condition pages connected to this study.